You have free access to this content

Alimentary Pharmacology & Therapeutics

Cover image for Vol. 31 Issue 9

May 2010

Volume 31, Issue 9

Pages 929–1050

  1. Review article

    1. Top of page
    2. Review article
    3. Systematic review
    4. Clinical trial
    5. Original articles
    1. You have free access to this content
  2. Systematic review

    1. Top of page
    2. Review article
    3. Systematic review
    4. Clinical trial
    5. Original articles
    1. You have free access to this content
      Systematic review: impact of constipation on quality of life in adults and children (pages 938–949)

      J. BELSEY, S. GREENFIELD, D. CANDY and M. GERAINT

      Article first published online: 20 FEB 2010 | DOI: 10.1111/j.1365-2036.2010.04273.x

  3. Clinical trial

    1. Top of page
    2. Review article
    3. Systematic review
    4. Clinical trial
    5. Original articles
    1. You have free access to this content
    2. You have free access to this content
      Clinical trial: interferential electric stimulation in functional dyspepsia patients – a prospective randomized study (pages 961–968)

      S. KÖKLÜ, G. KÖKLÜ, E. ÖZGÜÇLÜ, G. U. KAYANI, E. AKBAL and Z. HASÇELIK

      Article first published online: 5 FEB 2010 | DOI: 10.1111/j.1365-2036.2010.04256.x

    3. You have free access to this content
    4. You have free access to this content
  4. Original articles

    1. Top of page
    2. Review article
    3. Systematic review
    4. Clinical trial
    5. Original articles
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients (pages 1012–1017)

      J. S. BAJAJ, A. J. SANYAL, D. BELL, H. GILLES and D. M. HEUMAN

      Article first published online: 5 FEB 2010 | DOI: 10.1111/j.1365-2036.2010.04257.x

    4. You have free access to this content
      Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine response (pages 1018–1027)

      Y. ROTMAN, B. B. BORG, A. SOZA, J. J. FELD, A. A. MODI, R. LOOMBA, G. LUTCHMAN, E. RIVERA, E. DOO, M. G. GHANY, T. HELLER, A. U. NEUMANN, T. J. LIANG and J. H. HOOFNAGLE

      Article first published online: 16 FEB 2010 | DOI: 10.1111/j.1365-2036.2010.04263.x

    5. You have free access to this content
      Clinically significant liver injury in patients treated with natalizumab (pages 1028–1035)

      S. BEZABEH, C. M. FLOWERS, C. KORTEPETER and M. AVIGAN

      Article first published online: 16 FEB 2010 | DOI: 10.1111/j.1365-2036.2010.04262.x

    6. You have free access to this content
      Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus (pages 1036–1041)

      K. R. HERRLINGER, D. N. BARTHEL, K. J. SCHMIDT, J. BÜNING, C. S. BARTHEL, J. WEHKAMP, E. F. STANGE and K. FELLERMANN

      Article first published online: 18 FEB 2010 | DOI: 10.1111/j.1365-2036.2010.04267.x

    7. You have free access to this content
      Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis (pages 1042–1050)

      L. VANNELLA, E. LAHNER, J. OSBORN, C. BORDI, M. MIGLIONE, G. DELLE FAVE and B. ANNIBALE

      Article first published online: 18 FEB 2010 | DOI: 10.1111/j.1365-2036.2010.04268.x

SEARCH

SEARCH BY CITATION